ConductScience.org, home

Trial · NCT07881536

Comparison of M-TAPA, EOIP, and Local Infiltration for Pain Relief After Laparoscopic Cholecystectomy

NCT07881536, Completed, Pamukkale University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Comparison of M-TAPA, EOIP, and Local Infiltration for Pain Relief After Laparoscopic Cholecystectomy. Trials, record NCT07881536. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881536

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comparison of M-TAPA, EOIP, and Local Infiltration for Pain Relief After Laparoscopic Cholecystectomy
NCT number
NCT07881536
Status
Completed
Enrollment
90 participants, actual
Lead sponsor
Pamukkale University
Conditions
Postoperative Pain, Cholecystectomy, Laparoscopic, External Oblique Intercostal Plane Block, Modified Thoracoabdominal Nerve Block (M-TAPA)
Interventions
Modified Thoracoabdominal Nerve Block Through the Perichondrial Approach, External Oblique Intercostal Plane Block, Local anesthetic infiltration
First posted
2026-10-19
Last updated
2026-10-19

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPostoperative Pain Intensity at 2 Hours2 hours after surgery
Postoperative pain intensity during movement was assessed using the Visual Analog Scale (VAS) 2 hours after laparoscopic cholecystectomy. The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate less postoperative pain. VAS scores were compared among the M-TAPA, EOIP, and local anesthetic infiltration groups.
SecondaryPostoperative Pain Intensity at 15 Minutes15 minutes after surgery
Postoperative pain intensity during movement was assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate less pain. VAS scores were compared among the M-TAPA, EOIP, and local anesthetic infiltration groups.
SecondaryPostoperative Pain Intensity at 4 Hours4 hours after surgery
Postoperative pain intensity during movement was assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate less pain. VAS scores were compared among the M-TAPA, EOIP, and local anesthetic infiltration groups.
SecondaryPostoperative Pain Intensity at 8 Hours8 hours after surgery
Postoperative pain intensity during movement was assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate less pain. VAS scores were compared among the M-TAPA, EOIP, and local anesthetic infiltration groups.
SecondaryPostoperative Pain Intensity at 16 Hours24 hours after surgery
Postoperative pain intensity during movement was assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate less pain. VAS scores were compared among the M-TAPA, EOIP, and local anesthetic infiltration groups.
SecondaryProportion of Patients Requiring Rescue Opioid AnalgesiaWithin 24 hours after surgery
The proportion of patients requiring additional opioid analgesia after surgery was assessed using routinely collected medical records. Rescue opioid requirement was recorded as a binary outcome (yes/no) and compared among the M-TAPA, EOIP, and local anesthetic infiltration groups. Results were expressed as the number and percentage of patients requiring rescue opioid treatment.
SecondaryIncidence of Opioid-Related Adverse EventsWithin 24 hours after surgery
The incidence of opioid-related adverse events, including nausea, vomiting, pruritus, hypotension, bradycardia, respiratory depression, and sedation, was assessed using routinely collected postoperative medical records. The occurrence of these events was compared among the three analgesic groups.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07881536

GET https://conductscience.org/api/trials/v1/NCT07881536/registered